Monopoly and public benefit: a study on the balance between patent rights and easy market access of the public to patented pharmaceutical products and the role of Senate Bill No. 2139 on the Philippine pharmaceutical industry setting
Sa panahon ngayon, bawal magkasakit! This is a popular slogan of a pharmaceutical manufacturer selling its multivitamin capsule to the public. If we take the slogan literally, we will absolutely agree with the slogan. The use of pharmaceutical products is essential for the survival of any person in...
Saved in:
Main Authors: | Noel, Cyril Vincent S., Soliman, Miguel Paolo R. |
---|---|
Format: | text |
Language: | English |
Published: |
Animo Repository
2006
|
Subjects: | |
Online Access: | https://animorepository.dlsu.edu.ph/etd_bachelors/17685 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | De La Salle University |
Language: | English |
Similar Items
-
THE PHARMACEUTICAL PATENT PROTECTION IMPACT ON INDONESIA DRUGS PRICE
by: Perpustakaan UGM, i-lib
Published: (2009) -
Market for patents, monopoly, and misallocation
by: WEI, Shang-jin, et al.
Published: (2023) -
TRIPs and patenting activity: Evidence from the Indian pharmaceutical industry
by: Chadha, A.
Published: (2014) -
Patents and the developing world: A survey and regression analysis of the incentive role of patents on research and development in the Philippine pharmaceutical industry setting
by: Arcilla, Paola Marie D., et al.
Published: (2004) -
Patent Rights & International Public Health: Orphan Drugs
by: HEATHER ANGELINE ROBERTSON
Published: (2010)